Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (2) , 217-222
- https://doi.org/10.1023/a:1008323604269
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-CCancer Chemotherapy and Pharmacology, 1995
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancerBritish Journal of Cancer, 1989
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the futureCancer Treatment Reviews, 1983
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982